[1]
2025. Repurposing of Oxicam Derivatives to Inhibit NDM-1: Molecular Docking and Molecular Dynamic Simulation Studies. Al Mustansiriyah Journal of Pharmaceutical Sciences. 24, 4 (Jan. 2025), 343–360. DOI:https://doi.org/10.32947/ajps.v24i4.1029.